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Abstract 
Background: Six Plasmodium species are known to naturally infect humans. Mixed species infections occur regularly 
but morphological discrimination by microscopy is difficult and multiplicity of infection (MOI) can only be evaluated 
by molecular methods. This study investigated the complexity of Plasmodium infections in patients treated for micro‑
scopically detected non‑falciparum or mixed species malaria in Gabon.
Methods: Ultra‑deep sequencing of nucleus (18S rRNA), mitochondrion, and apicoplast encoded genes was used to 
evaluate Plasmodium species diversity and MOI in 46 symptomatic Gabonese patients with microscopically diagnosed 
non‑falciparum or mixed species malaria.
Results: Deep sequencing revealed a large complexity of coinfections in patients with uncomplicated malaria, both 
on species and genotype levels. Mixed infections involved up to four parasite species (Plasmodium falciparum, Plasmo-
dium malariae, Plasmodium ovale curtisi, and P. ovale wallikeri). Multiple genotypes from each species were determined 
from the asexual 18S rRNA gene. 17 of 46 samples (37%) harboured multiple genotypes of at least one Plasmodium 
species. The number of genotypes per sample (MOI) was highest in P. malariae (n = 4), followed by P. ovale curtisi 
(n = 3), P. ovale wallikeri (n = 3), and P. falciparum (n = 2). The highest combined genotype complexity in samples that 
contained mixed‑species infections was seven.
Conclusions: Ultra‑deep sequencing showed an unexpected breadth of Plasmodium species and within species 
diversity in clinical samples. MOI of P. ovale curtisi, P. ovale wallikeri and P. malariae infections were higher than antici‑
pated and contribute significantly to the burden of malaria in Gabon.
Keywords: Plasmodium malariae, Plasmodium falciparum, Plasmodium ovale wallikeri, Plasmodium ovale curtisi, Next‑
generation sequencing, Amplicon, Metagenomics
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Background
Malaria in humans is caused by six Plasmodium spe-
cies: Plasmodium falciparum, Plasmodium vivax, Plas-
modium malariae, Plasmodium ovale curtisi, P. ovale 
wallikeri and Plasmodium knowlesi which, although 
zoonotic, is an important pathogen in humans in sev-
eral regions of South East Asia [1, 2]. Whereas current 
research is focused on malaria caused by P. falciparum 
and increasingly also P. vivax, only relatively little effort 
has been dedicated to research on the other human 
malaria species. Infections with these species usually 
present with low parasitaemia; they can persist for long 
periods and sometimes remain asymptomatic. Besides 
mono-infections with one Plasmodium species, mixed 
infections within one individual occur [3, 4] and inter-
action between concurrent species—although not well 
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characterized—may play a role in disease progression 
and outcome [5, 6]. In clinical care, species determina-
tion is commonly performed by light microscopy, which 
has limited sensitivity  and specificity. Double, triple or 
even quadruple infections can be detected more reliably 
by molecular methods. In addition, presence of distinct 
genotypes (strains) of the same species cannot be dis-
cerned microscopically. An important proportion of nat-
urally occurring infections consists of multiple genotypes 
and “multiplicity of infection” (MOI) refers to the num-
ber of different genotypes of one species infecting a sin-
gle host [7]. For P. falciparum, MOI has been associated 
with several conditions, including age of the host, clinical 
severity, and transmission intensity [8]. Determination of 
within-host diversity may be a useful marker to assess the 
impact of interventions [9].
Genotyping of polymorphic genes such as merozo-
ite surface proteins (MSPs) and glutamate-rich protein 
(glurp), by nested-PCR is a gold standard method for 
assessing MOI in P. falciparum infections. An alterna-
tive approach uses next generation sequencing (NGS) 
technologies, which allow high-resolution analyses of  a 
heterogeneous mixture of the parasites within the host 
[10]. Compared to the standard method, NGS revealed 
an up to six times higher MOI of P. falciparum in a previ-
ous study [11]. By generating multiple reads per sample 
(usually between 100 and 10,000), this technique is very 
sensitive and able to detect minor alleles. Recent analy-
sis of the conserved cytochrome b gene (cytb) using NGS, 
detected multiple genotypes infections (up to 4) includ-
ing non-falciparum species in 10% of 437 samples col-
lected in Cameroon [12].
Here, a metagenomics sequencing based approach 
was applied using three pan-Plasmodium primer sets for 
nucleus (18S rRNA), mitochondrion (cytb), and apico-
plast (clpC) encoded genes to characterize the different 
Plasmodium species that infect patients with microscopi-
cally diagnosed non-falciparum malaria in the depart-
ment of Tsamba-Magotsi, Gabon, a remote area of rural 
Central Africa [13]. By this approach, parasite diversity 
in 46 Gabonese symptomatic patients is described, that 
are sampled over a time period of 3 years and provide a 
baseline for research on the epidemiology and potential 




Parasite DNA for this study was extracted from dried 
blood spots on filter paper of 46 patients with uncom-
plicated, microscopically diagnosed non-falciparum or 
mixed species malaria, which represents a minority of 
malaria cases in the region but was found in more than 
20% in a cross-sectional survey in the area [13]. Blood 
samples from two clinical studies  were used. From the 
first study (recruited 2008–2010) samples of 30 patients 
were included, details of patients’ characteristics are 
published elsewhere [14]. Briefly, patients with uncom-
plicated malaria, defined as symptoms and presence of P. 
ovale or P. malariae in thick blood smear, either as mono 
or mixed infection were included after informed consent 
was given. All patients received artemether-lumefantrine 
as anti-malarial chemotherapy and recovered from the 
infection. From the second study (recruited 2012–2013) 
16 samples of patients that were included for molecular 
assessment of Plasmodium spp. were used. Both studies 
were approved by the regional ethics committee (Comité 
d’Ethique Régional Indépendant de Lambaréné) and fol-
lowed the principles of the Declaration of Helsinki in its 
5th revision.
Amplification and 454 sequencing
Capillary blood collected on filter paper from patients 
prior to anti-malarial treatment was processed for DNA 
extraction using QIAamp DNA blood mini kit (Qia-
gen) according to the manufacturer’s specifications. For 
malaria species and genotype identification using NGS, 
we designed three Plasmodium genus-specific primer 
sets from the conserved region flanking the highly pol-
ymorphic nucleotide sequence of the 18S rRNA, the 
mitochondrial cytochrome b (cytb) and the apicoplast 
caseinolytic protease C gene (clpC). All primers were 
5′-fused to universal tail sequences. Using 2.5 µl of DNA 
extract, target specific PCR was carried out by using 
Phusion High-Fidelity PCR master mix (Finnzymes) 
for 35 cycles. The 454 MID kit (Multiplicom) was used 
to perform subsequent PCR addition of a 454-adaptor 
sequence linked to multiplex identifiers (MID) in order 
to discriminate the patients in following analysis steps. 
Here, the 100 times diluted first round PCR product was 
used as template and amplified for 20 cycles. All reac-
tions were carried out using a Biometra T2 professional 
Thermocycler. The corresponding primer sequences and 
annealing temperature are given in Table 1. PCR ampli-
cons were purified using AmPure XP kit (Agencourt) 
according to standard procedures (Roche Technical Bul-
letin No. 2011-007). Quality and purity of amplicons 
were checked using the Agilent DNA 1000 assay kit on 
a 2100 Bioanalyzer (Agilent Technology) and subse-
quently quantified using the Quant-iT Picogreen dsDNA 
reagent (Invitrogen) on a Fluoroskan Ascent microplate 
Fluorometer (ThermoScientific). Based on individual 
DNA concentration, each amplicon was diluted to  107 
molecules/µl stock solutions. Amplicons were pooled in 
equimolar concentration to generate a single library and 
further processed following the GS Junior emPCR LibA 
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method (Version April 2011) for emulsion PCR (emPCR) 
using a low copy per bead ratio (0.25 cpb). 500,000 DNA 
enriched beads were loaded onto a GS Junior Picotiter 
plate following the GS Junior sequencing manual (Ver-
sion April 2011) and sequencing was performed in both, 
forward and reverse direction using the GS Junior Tita-
nium sequencing kit.
Sequence analysis
Figure  1 summarizes the bioinformatics pipeline used 
to process Plasmodium sequence reads generated by GS 
Junior. The sfffile program (SFF Tools, Roche) was used 
to split raw sequence data based on multiplex identi-
fier (MID). Low quality and short reads (< 200 bp) were 
excluded prior to analysis. Sequencing errors (PCR noise) 
and homopolymer stretches were corrected with Aca-
cia [15]. Chimeric sequences were detected by using the 
software Uchime [16] and excluded from further analy-
sis. Both programs were run with default parameters. 
High-quality filtered reads were mapped to a local refer-
ence database comprising 18S rRNA, cytb and clpC gene 
sequences of Plasmodium spp. downloaded from Gen-
Bank (Table 2). Unmapped sequences were further ana-
lyzed using BLAST searches against the NCBI nucleotide 
database and the Plasmodium database (Plasmodb) [17]. 
Single nucleotide polymorphisms (SNPs) in the analyzed 
genes were determined using the probabilistic variant 
detection method-implemented in the CLC Genomics 
Workbench 5 (CLC Bio, Aarhus, Denmark). Haplotypes 
were determined with DnaSP [18] using the following 
thresholds: SNP frequency equal or greater than 10% as 
well as per gene read coverage ≥  10 fold. Plasmodium 
species genotypes were identified by querying consensus 
sequences against the NCBI GenBank database. All SNP 
positions were reported as absolute positions in the best 
matching NCBI reference sequence. Polyclonal infections 
were identified based on SNPs in the variable region (V5) 
of the 18S gene, giving the number of genotypes infecting 
one host (referred to as MOI). The number of genotypes 
obtained by this marker typically leads to an underesti-
mation of polyclonality and characterization of geno-
types based on more polymorphic genes might better 
estimate the scale of multiple infections. However, this 
would make comparisons between species more difficult 
as different genes would be evaluated. 
Results
Sequence statistics from patients
The 46 patient samples were analyzed in batches of four 
sequencing runs on a Roche 454 GS Junior sequencer. 
The median number of raw reads assigned to each sample 
was 3829 (range 1563–11,590). However, after removal 
of chimeric and low-quality reads, the final informative 
sequences available for each sample was 3165 (range 
655–9091). The sequence coverage for each locus per 
sample is reported in the Additional file 1. Differences in 
coverage between loci and overall batch to batch varia-
tion in the number of raw reads were observed. However, 
there is no evidence that this substantially influences the 
results, as the overall coverage per sample is expected to 
be high enough to detect minor genotypes.
Species discrimination by deep sequencing
Each filtered read was mapped to the target genes of 
the reference species for identification. Mixed-spe-
cies malaria infections identified by the metagenomics 
approach were also detected by conventional nested-PCR 
in combination with gel electrophoresis [14]. By NGS, it 
was possible to achieve a more detailed resolution of the 
species diversity that included identification of nine novel 
genotypes and polyclonal infections using the same gene 
in all six investigated Plasmodium spp.
Table 1 Primers used in this study
a Underlined region represents universal tag sequences
b Snounou et al. [25]
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Fig. 1 Bioinformatics pipeline. Flowchart describing bioinformatic pipeline. The pipeline is divided into a quality control part, mapping and variant 
calling part. * used with default settings
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A minimum of three high quality reads had to be 
assigned to at least one of the target loci to be included 
in the analysis. There were 44 (96%) patients with P. fal-
ciparum, 15 (33%) with P. malariae, 7 (15%) with P. ovale 
curtisi, and 8 (17%) with P. ovale wallikeri infections. 
Different parasite combinations in mixed infections 
and up to four species in the same host were detected. 
Of 46 samples, 24 contained only P. falciparum, another 
two contained only P. malariae or P. ovale wallikeri. 
The remaining samples contained double (n  =  15), tri-
ple (n = 2), and quadruple (n = 3) Plasmodium species 
infections (Table 3).
Plasmodium falciparum infections
Plasmodium falciparum specific sequence reads were 
identified in all but 2 (96%) of the study samples. Based 
on the 18S A-type gene sequence, four novel genotypes 
(GenBank KJ170098—KJ170101) were identified, all are 
a single nucleotide polymorphism when compared to 
the reference sequence (GenBank JF681166) as shown 
in Table  4. No other sequences with these SNPs were 
found when a similarity search against GenBank was per-
formed. Co-infections with other species were found in 
20 patients (45%).
Plasmodium malariae infections
A total of 15 infections were observed with the quartan 
malaria parasite, one as mono and the remaining ones 
as co-infection with other species. Based on the 18S 
rRNA gene, the parasites were further characterized as 
P. malariae-Asian type 1 (n = 1) and P. malariae-Asian 
type 2 (n  =  14) [19]. Two unique genotypes (GenBank 
KJ170105, KJ170106) similar to Plasmodium cf. malariae 
type 2 were obtained (GenBank AF488000, 99% identity). 
Each genotype is defined by either a single nucleotide 
substitution or insertion compared to P. malariae-Asian 
type 2 (Table 4) (see comments below).
Plasmodium ovale wallikeri and P. ovale curtisi infections
Plasmodium ovale wallikeri and P. ovale curtisi were 
identified in the dataset supported by reads matching to 
specific 18S, cytb, or clpC sequences of the two P. ovale 
species (Additional file 1). In addition, mixed infections 
of P. ovale curtisi and P. ovale wallikeri were observed in 
four patients (Table 3).
Table 2 Plasmodium spp. reference sequences used 
for 454-reads mapping
Plasmodium species GenBank 
Acc.
Plasmodium falciparum 18S ribosomal RNA gene (S‑type) HQ283222.1
Plasmodium falciparum 18S ribosomal RNA gene (A‑type) JQ627152.1
Plasmodium vivax 18S ribosomal RNA gene (A‑Type) JQ627158.1
Plasmodium vivax 18S ribosomal RNA gene (O‑Type) U93235.1
Plasmodium vivax 18S ribosomal RNA gene (S‑Type) U93234.1
Plasmodium berghei 18S ribosomal RNA gene M19712.1
Plasmodium berghei 18S ribosomal RNA gene M14599.1
Plasmodium malariae 18S ribosomal RNA gene M54897.1
Plasmodium ovale 18S ribosomal RNA gene AB182493.1
Plasmodium ovale 18S ribosomal RNA gene AB182489.1
Plasmodium yoelii 18S ribosomal RNA gene AF180727
Plasmodium knowlesi 18S ribosomal RNA gene JF714686.1
Plasmodium cf. inui 18S ribosomal RNA gene FJ619091.1
Plasmodium simiovale 18S ribosomal RNA gene AB287287.1
Plasmodium ovale wallikeri cytochrome b gene KJ930413.1
Plasmodium ovale curtisi cytochrome b gene KP050432.1
Plasmodium malariae cytochrome b gene LT594637
Plasmodium vivax cytochrome b gene JN788776
Plasmodium falciparum cytochrome b gene KC175316.1
Plasmodium berghei cytochrome b gene DQ414645.1
Plasmodium knowlesi cytochrome b gene JQ345523.1
Plasmodium spp. from Gabon cytochrome b gene AF069623.1
Plasmodium yoelii cytochrome b gene DQ414658.1
Plasmodium falciparum HB3 clpC gene for caseinolytic 
protease C
DQ642846.1
Plasmodium ovale curtisi clpC gene for caseinolytic 
protease C
KP050446.1
Plasmodium ovale wallikeri clpC gene for caseinolytic 
protease C
KP050439
Plasmodium malariae clpC gene for caseinolytic protease 
C
AB649418.1
Plasmodium vivax clpC gene for caseinolytic protease C AB471871.1
Plasmodium gaboni clpC gene for caseinolytic protease C HQ842630.1
Plasmodium knowlesi clpCgene for caseinolytic protease C AB471880.1
Plasmodium simiovale clpCgene for caseinolytic protease C AB471881.1
Plasmodium cf. ovale clpC gene for caseinolytic protease C HQ842632.1
Plasmodium yoelii clpC gene for caseinolytic protease C DQ417625.1
Plasmodium berghei clpC gene for caseinolytic protease C AB649421.1
Table 3 Number of  Plasmodium spp. infections detected 
by deep sequencing
Pfal, P. falciparum; Pmal, P. malariae; Poc, P. ovale curtisi; Pow, P. ovale wallikeri
Species Infection type Patients (n)
Pfal Mono infection 24
Pmal Mono infection 1
Pow Mono infection 1
Pfal, Pmal Double infection 10
Pfal, Poc Double infection 3
Pfal, Pow Double infection 2
Pfal, Pmal, Pow Triple infection 1
Pfal, Poc, Pow Triple infection 1
Pfal, Pmal, Poc, Pow Quadruple infection 3
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All of P. ovale curtisi genotypes identified from the 
samples were similar to previously submitted sequences. 
Three novel genotypes of P. ovale wallikeri were identified 
based on 18S rRNA gene sequence polymorphisms (Gen-
Bank KJ170102—KJ170104). One of them possesses a 
single nucleotide substitution at position 1128. Genotype 
2 and Genotype 3 showed six and two nucleotide substi-
tutions when compared to the corresponding reference 
sequence (GenBank AB182493), respectively (Table 4).
Detection of P. ovale curtisi 18S rRNA gene variant
In three of the samples a fraction of reads (range 10–15 
reads) could not be mapped to any reference sequence. 
A sequence identity search against the NCBI database 
initially did not show significant similarity with respect 
to query coverage and maximum identity with any of 
the Plasmodium spp. 18S sequence. A 1078  bp length 
sequence was constructed (GenBank KJ170108), span-
ning the variable regions 4 and 7 along with the 454 
amplicon target (V5) by PCR and Sanger sequencing 
with pan-Plasmodium and specific primers, respectively 
(Fig.  2). The generated sequence showed 100% similar-
ity to the draft genome of P. ovale (P. ovale Blast Server, 
Sanger Institute) and a recently discovered 18S rRNA 
gene variant (GenBank KF696378) of P. ovale curtisi [20].
Multiplicity of infection
An overview of the MOI based on the variable region 
(V5) of the 18S gene for the different Plasmodium spe-
cies is given in Table  5. The relative frequency of each 
genotype per sample based on the number of reads is 
plotted in Fig. 3. Multiple P. falciparum genotype (MOI) 
infections were detected in five patients with a maximum 
of two genotypes per sample. All P. falciparum mono-
infections carried a single genotype, except one patient 
(MID15) who carried two genotypes. Multiple genotype 
infections were found in two of the seven P. ovale cur-
tisi infected samples (MOI of 3). Among eight samples 
infected with P. ovale wallikeri, six harboured multiple P. 
ovale wallikeri genotypes (MOI of 2–3). Analysis of the 
cytb and clpC reads showed 100% similarity to the pub-
lished reference sequences. Nine samples contained mul-
tiple P. malariae genotypes (MOI of 2–4). The number of 
different genotypes per sample was greater for P. malar-
iae when compared to the other species, showing up to 
four genotypes within one sample.
Reads mapping to cytb and clpC showed 100% 
sequence identity to the reference sequences for all 
species (KC175316 and DQ642846 for P. falciparum; 
KJ930413 and KP050439 for P. ovale wallikeri; KP050432, 
KP050446 for P. ovale curtisi; HQ842634 and AB649418 
for P. malariae).
Discussion
Gabon is highly endemic for malaria with perennial 
transmission of P. falciparum and co-endemicity of P. 
malariae and P. ovale [21, 22]. Gabon has a low popu-
lation density (6.7 persons per square km in 2015) [23], 
but population mobility is high, and a large fraction of 
inhabitants live close to or within non-cultivated areas, 
that contain diverse and intact wildlife [24]. Originally, 
the study was designed to assess the efficacy of arte-
misinin combination therapy (artemether-lumefantrine) 
in uncomplicated non-falciparum and mixed species 
Table 4 Polymorphic Nucleotide positions compared to GenBank best-hits reference sequences
Each dot represents nucleotide similarity with the GenBank reference sequences. Dashes represent deletions. Numbers at the column header represent nucleotide 
positions corresponding to GenBank reference sequences
Genotypes Origin 386 407 504 517 529
P. falciparum (JF681166) China G T G A C
P. falciparum (KJ170098) Gabon A C . – .
P. falciparum (KJ170099) Gabon . . . . G
P. falciparum (KJ170100) Gabon A . . . .
P. falciparum (KJ170101) Gabon . . A . .
1036 1189
P. malariae (AF488000) Myanmar G –
P. malariae (KJ170105) Gabon . T
P. malariae (KJ170106) Gabon A T
1005 1026 1109 1112 1128 1131 1132
P. ovale wallikeri (AB182493) Indonesia A C G G A G A
P. ovale wallikeri (KJ170102) Gabon . . . . G . .
P. ovale wallikeri (KJ170103) Gabon G T A A A G
P. ovale wallikeri (KJ170104) Gabon G T . . . . .
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Fig. 2 Schematic representation of the sequencing approach by Sanger method to determine the new 18S rRNA gene type sequence of P. ovale 
spp. Conserved pan‑Plasmodium 18S primers (rPLU6 and rPLU5) were first used to amplify the gene spanning three variable regions and two 
conserved blocks. The nucleotide sequences upstream and downstream of the 454 sequencing target region (V5) of the gene were determined 
by direct sequencing of the initial product using p‑AVL‑F and p‑AVL‑R primers. Partial 18S gene (1078 bp length) was obtained by assembling 454 
reads with the sequences obtained using p‑AVL‑F and p‑AVL‑R primers
Table 5 Multiplicity of Plasmodium spp. infections
Pfal, P. falciparum; Pmal, P. malariae; Poc, P. ovale curtisi; Pow, P. ovale wallikeri; na, no 18S sequence obtained
Sample id Infecting species Number of genotypes for each species
Pfal Pmal Poc Pow Total (MOI)
MID01 Pmal 4 4
MID11 Pfal, Pmal 2 2 4
MID15 Pfal 2 2
MID16 Pfal, Pmal, Poc, Pow 1 4 na 2 7
MID23 Pfal, Poc, Pow 2 2 4
MID24 Pfal, Poc 1 3 4
MID25 Pfal, Pmal 1 3 4
MID27 Pfal, Pmal 2 2 4
MID28 Pfal, Pmal, Poc, Pow 2 2 1 1 6
MID30 Pfal, Pmal, Pow 1 na 2 3
MID31 Pfal, Poc 1 3 4
MID32 Pfal, Pow 1 3 4
MID34 Pfal, Pmal 1 2 3
MID38 Pfal, Pow 1 3 4
MID41 Pfal, Pmal 1 2 3
MID43 Pfal, Pmal 1 2 3
MID46 Pow 2 2
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malaria [14]. Species identification was based on micros-
copy and verified by species-specific nested PCR [25]. 
Here, a metagenomics approach was designed based on 
high throughput sequencing to re-analyze the diversity of 
Plasmodium spp. Two studies were conducted recently 
using NGS to explore the evidence of zoonotic transmis-
sion of Plasmodium spp. in humans [12, 26]. These stud-
ies were designed to differentiate Laverania species of 
apes and humans based on the diagnostic single nucle-
otide polymorphism found in the mitochondrial DNA 
(mtDNA). The current study expanded the target genes 
to three genes including the 18S rRNA and clpC gene to 
improve accuracy and assess the diversity of Plasmodium 
populations in blood samples of malaria patients. The 18S 
rRNA gene is one of the most commonly used targets in 
the molecular diagnosis of Plasmodium spp. including a 
widely used nested PCR and a number of real-time PCR 
assays [25, 27]. Due to the high copy numbers (5–10 cop-
ies), and the presence of both highly conserved and varia-
ble regions, 18S genes are well-suited and frequently used 
molecular targets for the detection and discrimination of 
Plasmodium species. Until to date, no study has applied 
these genes to identify Plasmodium spp. using NGS.
As expected, results obtained by conventional species-
specific PCR were reproduced upon DNA re-extraction 
and analysis by deep sequencing. Beyond this, this analysis 
gives a snapshot in time; showing the breadth of co-infec-
tions and an unbiased estimate of infection intensity of 
the different Plasmodium spp. in a cohort of patients with 
uncomplicated malaria. P. malariae is widespread in Africa 
but rarely characterized by molecular techniques. Based 
on morphological differences and sequence polymor-
phisms compared to genuine P. malariae (Uganda CDC 
isolate), two possible subtypes were identified in Asia: P. cf. 
malariae type 1 and P. cf. malariae type 2 [19]. It would be 
interesting to investigate if the Asian and the Ugandan type 
differ in their sensitivity to artemisinins, since a reduced 
sensitivity of an infection in Uganda has been observed 
[28, 29] but all patients in this study responded well to 
the treatment [14]. Only few studies have looked at MOI 
of non-falciparum species. It has been shown in one study 
that P. malariae infections in Malawi, often consisted of 
multiple genotypes per infected individual and showed a 
surprisingly similar pattern when compared to P. falcipa-
rum [30]. Up to five genotypes were detected from a single 
sample by multilocus genotyping based on microsatellite 
markers in asymptomatic carriers [31]. There are also up 
to four different genotypes of P. malariae in two patients 
and three different genotypes of P. ovale wallikeri and P. 
ovale curtisi each in two patients in the here presented 
study based on the 18S region, respectively. Many of the 
P. falciparum infections were on the contrary caused only 
by one genotype when judged by polymorphisms in the 
18S rRNA gene. These results are surprising as one would 
assume a lower MOI in P. malariae and both P. ovale spe-
cies as the reported prevalence in this region is low. How-
ever, results are also in line with earlier findings from 
Cambodia for P. ovale [32], reflecting the possibility that 
these parasite species are more prevalent than previously 
thought. Evidence suggests that P. malariae is not com-
pletely species-specific and also prevalent in non-human 
primates [29, 33], having a larger pool of hosts. In addition, 
infections with these species might be more chronic and 
long-lived so that multiple genotypes could accumulate 




























































































































































Fig. 3 Relative frequency of each Plasmodium spp. genotype within 
one infected host. a Relative frequency of P. falciparum genotypes 
(defined by the 18S A‑type gene variation); b relative frequency of P. 
malariae genotypes. c Relative frequency of P. ovale curtisi and P. ovale 
wallikeri
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to define a genotype in this study is not as polymorphic as 
markers commonly used to define genotypes; for example 
microsatellites, or genes like msp1, msp2 and glurp for P. 
falciparum [34]. It is expected that the number of geno-
types are larger if more polymorphic markers had been 
used. The advantage of our approach is that homologous 
genes between the different species can be compared and 
one can get an impression on the population structure of 
the co-infecting species. Particularly, because there is no 
evidence that selection leads to different mutation rates in 
this gene region for the different species, this can be one 
approach to compare diversity between species. These 
results highlight the potential of amplicon-based high 
throughput sequencing combined with adequate polymor-
phic markers to obtain reliable molecular characterization 
of other non-falciparum species, where only limited data 
are available. Despite short-read length (< 400 nt) gener-
ated by the NGSs technique, significant dimorphism of 
the targeted genes allowed accurate assignment of reads 
between P. ovale curtisi and P. ovale wallikeri. By using a 
multiple locus approach, co-infections of the two P. ovale 
species in four patients were detected, adding yet further 
evidence that the two species do not recombine in nature. 
The primer for the cytb gene was selected from a region 
not including the ape-specific SNPs leading to potential 
inability to detect non-human species. However, there was 
no evidence for non-human Plasmodium species infec-
tions based on the analysis of the other two genes.
Two structurally distinct types of 18S rRNA have been 
reported in many Plasmodium species [35]. In P. falci-
parum, type A and type S has been described with up to 
11% difference in the sequences between the two types 
[36]. The existence of paralogous 18S rRNA genes in P. 
malariae, P. ovale wallikeri and P. ovale curtisi genome is 
not well described until now. The new type of 18S rRNA 
gene sequence from this study, together with the recent 
report [20], clearly suggests that at least two different 
forms exist in P. ovale curtisi and P. ovale wallikeri [20]. 
A real-time PCR based assay targeting this new sequence 
showed high sensitivity and specificity and can be used 
for the differential diagnosis of P. ovale species infections 
(unpublished observation).
The main limitation of techniques that involve PCR 
is the inherent risk of contamination and the NGS 
approach is no exception. Thus, an essential aspect of 
sample preparation for sequencing is the careful adop-
tion of experimental strategies aimed at minimizing 
cross-contamination. In addition, amplicon-based NGS 
are prone to errors such as chimeras, a well-known issue 
in metagenomics analyses of environment bacterial com-
munities. Several measures to minimize and avoid these 
underlying problems at each step, including a non-tem-
plate control to check contamination of reagents dur-
ing each target amplification, a separate work station for 
DNA extraction, PCR assay set-up, and post-PCR pro-
cessing are necessary.
The true burden of disease caused by P. malariae and 
the P. ovale species is not known as these species are 
mostly underdiagnosed despite their worldwide distribu-
tion [29]. Malaria caused by these parasites is generally 
more benign when compared to P. falciparum. Infec-
tions present often with a low level parasitaemia that is 
difficult to detect by microscopy, but might cause a more 
chronic illness associated with anaemia [37]. Recent 
reports reveal a higher than expected prevalence of these 
species in many African countries when diagnosed by 
PCR [38], going in line with the deep sequencing result. 
Currently, deep sequencing methods may not be appli-
cable in field settings but can be helpful in longitudinal 
epidemiological studies to investigate the emergence 
and change in composition of plasmodial species. The 
study population was highly selected and represents only 
a minority of all malaria cases in the area. Microscopic 
species differentiation is not reliable, particularly when 
parasite density is low. Therefore, it is unlikely that the 
appearance of new plasmodial species is noted without 
molecular techniques. Diversity of the two P. ovale spe-
cies, and characterization of the P. malariae population 
should be taken into consideration for the design, end-
points and feasibility of malaria control strategies, e.g. 
longer follow up or separate treatment of hypnozoites. 
Fortunately, artemisinin combination therapy was effica-
cious in all patients of the present study but emergence 
of novel zoonotic species or isolates that may be inher-
ently less responsive to current treatment regimens shall 
be detected early, to provide a specific treatment regi-
men, especially when severe malaria can occur, as in the 
case of P. knowlesi infections. The impact on malaria 
vaccine development shall even be stronger since cross-
protection between Plasmodium species is limited [39] 
and mechanisms of high-grade protection are often not 
known but likely to be different for each parasite species.
Conclusions
Parasite diversity of Plasmodium species in naturally 
acquired malaria is larger than expected. The population 
structure, especially of non-falciparum species, needs 
further assessments to better understand the prevalence 
and biology of these parasites. Metagenomics analysis by 
deep sequencing provides a tool for this and boosts the 
understanding of naturally acquired malaria. It will be 
exciting to expand such investigations to other malaria-
endemic regions and larger cohorts.
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